[The use of Vasaprostan (prostaglandin E1) in treating patients with obliterating arterial diseases of the lower extremities].
Lebedev
L V
LV
Afonin
D N
DN
D000527:Alprostadil / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D006801:Humans; D007866:Leg / Q000098:blood supply*
D000527:Alprostadil
Primenenie Vazaprostana (prostaglandina E1) pri lechenii bol'nykh s obliteriruiushchimi zabolevaniiami arteriĭ nizhnikh konechnosteĭ.